Deep Ventricular "Dive-In" during Valve-in-Valve transcatheter aortic valve replacement in an externally mounted leaflet bioprosthesis [0.03%]
经导管主动脉瓣置换术中深心室"Dive-In"现象在外部支架式生物瓣膜中的发生
Akihiro Ikuta,Satoki Oka,Syunsuke Matsushita et al.
Akihiro Ikuta et al.
Ischemic time is associated with procedure-related no-reflow/slow-flow during perfusion balloon-assisted percutaneous coronary intervention in acute coronary syndrome [0.03%]
缺血时间与急性冠状动脉综合征患者血管内成像指导的球囊辅助经皮冠状动脉介入治疗术中无复流/慢流相关性研究
Hiroshi Abe,Dai Ozaki,Masato Tomaru et al.
Hiroshi Abe et al.
Perfusion balloons have been shown to reduce the incidence of no-reflow/slow-flow in thrombotic lesions among patients with acute coronary syndrome (ACS). However, predictors of procedure-related no-reflow/slow-flow during perfusion balloon...
When anatomy challenges intervention: successful transcatheter closure of a multi-fenestrated ASD with atrioventricular valve rim deficiency presenting as platypnea-orthodeoxia syndrome [0.03%]
解剖结构异常心内缺损的封堵术：房间隔多孔型缺损伴二/三尖瓣成形不全致直立性呼吸困难综合征患者的封堵治疗一例
Ryotaro Maeda,Takeshi Nakamura,Michiyo Yamano et al.
Ryotaro Maeda et al.
Intravascular imaging guidance for percutaneous coronary intervention and clinical outcomes: meta-analyses of randomized controlled trials [0.03%]
血管内影像指导经皮冠状动脉介入治疗的临床疗效meta分析研究
Yuriko Hiruma,Tetsuya Saito,Mariko Sugii et al.
Yuriko Hiruma et al.
Recent randomized trials have questioned the incremental benefit of intravascular imaging-guided PCI, and the populations most likely to benefit remain uncertain. This study evaluates the long-term outcomes of intravascular imaging-guided P...
Intracardiac air mimicking an atrial septal occluder device during left atrial appendage closure [0.03%]
左心耳闭合术中误诊为空气的房间隔封闭器装置
Yu Yoshida,Yoichi Takaya,Rie Nakayama et al.
Yu Yoshida et al.
Differential impact of institutional procedural volume on outcomes of transcatheter and surgical strategies for concomitant aortic stenosis and coronary artery disease: a nationwide registry study [0.03%]
机构程序量对经导管和外科治疗联合主动脉瓣狭窄和冠状动脉疾病的策略结果的差异影响：全国登记处研究
Kensuke Takagi,Kentaro Mitsui,Yoko Sumita et al.
Kensuke Takagi et al.
Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist in elderly patients. Surgical aortic valve replacement (SAVR) with coronary artery bypass grafting (CABG) has been the standard treatment. However, transcatheter aort...
Residual inflammatory risk after percutaneous coronary intervention: current insights and future perspectives [0.03%]
经皮冠状动脉介入治疗后的残留炎症风险：当前见解与未来展望
Tomoya Hara,Masataka Sata
Tomoya Hara
Despite advances in percutaneous coronary intervention (PCI) and contemporary secondary prevention, recurrent cardiovascular events remain a major clinical challenge. Increasing evidence suggests that persistent vascular inflammation contri...
Correction: Angiography- and IVUS-tip-detection-guided 3D wiring for CTO and non-CTO percutaneous coronary interventions [0.03%]
纠正：用于CTO和非CTO经皮冠状动脉介入治疗的血管造影和IVUS探头检测引导的3D导丝技术
Atsunori Okamura,Ryohei Yoshikawa,Kota Tanaka et al.
Atsunori Okamura et al.
Published Erratum
Cardiovascular intervention and therapeutics. 2026 Jun 23. DOI:10.1007/s12928-026-01313-y 2026
A scaffold-degradable single-rivet ASD occluder with amplatzer-like design: a multicenter randomized controlled trial [0.03%]
一种类似Amplatzer设计的可降解单铆栓ASD封堵器：多中心随机对照试验
Liqing Zhao,Jiawei Gao,Xin Zhou et al.
Liqing Zhao et al.
Metallic atrial septal defect (ASD) occluders are associated with various mid- to long-term complications. To address this, our team developed a novel biodegradable Pansy ASD occluder, and this multicenter RCT aimed to evaluate its effectiv...
Association between short (≤ 30-day) dual antiplatelet therapy and 1-year major adverse cardiac events after drug-coated balloon-based non-stent percutaneous coronary intervention following optimal lesion preparation: a propensity score-based cohort study [0.03%]
基于最佳病变准备的药物涂层球囊基非支架经皮冠状动脉介入术后短期（≤30天）双联抗血小板治疗与1年主要不良心血管事件的关系：一项倾向性评分法队列研究
Shuhei Kuroda,Takahiro Sawada,Ryota Yui et al.
Shuhei Kuroda et al.
Drug-coated balloon (DCB)-based non-stent percutaneous coronary intervention (PCI) may allow shorter dual antiplatelet therapy (DAPT), but whether a ≤ 30-day regimen is associated with worse outcomes remains unclear, particularly in patien...